Bpost NV (BPOST)
Euronext Brussels · Belgium · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 1.094 |
|---|---|
| 52-week range | 1.070 – 2.380 |
| Return, 1 month / 3 months | −7.1% / −29.9% |
| Return, 1 year / 3 years | −49.5% / −76.8% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 33.1% |
| Worst drawdown (1 year) | -53.4% |
| Average daily value traded | 0.42M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
bpost is the Belgian postal and parcel company based in Brussels. It collects, sorts and delivers letters and parcels across Belgium and also handles international mail and parcel traffic. Through its retail network it offers postal services, parcel drop-off and collection, and financial and insurance products to households and businesses. It also provides logistics and distribution services for business customers, including e-commerce deliveries, and runs press distribution and other mail-related services in Belgium.
Bpost NV trades under the code BPOST on the Euronext Brussels in Belgium, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bpost NV (BPOST) trades on the Euronext Brussels in Belgium. It last closed at EUR 1.094 on 22 October 2026.
Its price-based Market X-Ray is 25 out of 100 (a weak price profile), ranking 92 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 49.5% and over the last three months it fell 29.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 11 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -34.5% | ||
| From 52-week high | -53.2% | ||
| Momentum | 10 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -29.9% | ||
| 6-month return | -41.9% | ||
| 12-month return, skipping the last month | -45.6% | ||
| Stability (higher is calmer) | 29 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -53.4% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.42M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.5% |
|---|---|
| 1 month | −7.1% |
| 3 months | −29.9% |
| 6 months | −41.9% |
| 1 year | −49.5% |
| 3 years | −76.8% |
| 5 years | −82.2% |
Signals
| 50-day / 200-day average | 1.208 / 1.670 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.033 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 May 2024 | EUR 0.1300 |
| 18 May 2023 | EUR 0.4000 |
| 16 May 2022 | EUR 0.4900 |
| 18 May 2020 | EUR 0.1100 |
| 5 Dec 2019 | EUR 0.6200 |
| 13 May 2019 | EUR 0.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.